U/S IDs Response to Propranolol in Infantile Hemangioma

Share this content:
U/S IDs Response to Propranolol in Infantile Hemangioma
U/S IDs Response to Propranolol in Infantile Hemangioma

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- For patients with infantile hemangiomas, serial ultrasonography can be used to show response to propranolol treatment, according to a study published online Nov. 4 in the International Journal of Dermatology.

Anita Rotter, M.D., from the University of São Paulo Medical School in Brazil, and colleagues examined the use of serial ultrasonography as an adjunctive tool for assessment of IH treatment with propranolol in a retrospective study. Data were reviewed for 19 patients with IH treated with propranolol from January 2009 to March 2014. The authors obtained data on individual IH volume at the beginning and at least six months after treatment onset, and assessed overall volume reduction.

The researchers found that there was a significant reduction in IH volume of about 0.51 cm³. This corresponded to a 47 percent average reduction in the final volume relative to the initial volume.

"Ultrasonographic measurements contribute to demonstrate tumor regression and IH response to propranolol," the authors write. "Thus, ultrasonography is an important instrument to guide therapeutic strategies."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »